Curaleaf forced to remove thousands of medical marijuana products from NY dispensaries

August 15, 2022
AggregatedNews
New York, Producers
1 Comment

Curaleaf, one of New York’s medical marijuana operators, has pulled tens of thousands of units of cannabis from dispensary shelves after the company switched to an unauthorized way of labeling potency that led patients to believe the marijuana they purchased was much stronger than usual.

Curaleaf began displaying “dry weight” measurements on its products in July without approval from the Office of Cannabis Management and without alerting customers. While all products in NY show “wet weight” measurement, the “dry weight” method shows significantly higher THC percentages, making the marijuana more enticing for buyers looking for the biggest bang for their buck.

For example, the same product could show a THC percentage of 20% using wet weight measurement – but as high as 37% using dry weight testing.

“The higher the potency of the flower, the more sales of that item we see,” said Geoff Brown, a pharmacist at MedMen in Buffalo and co-founder of CannaBuff magazine. The switch to dry weight testing resulted in “a remarkable increase in sales” of Curaleaf’s product at his store, Brown said, but left dispensary staff with questions over the significantly higher potency. [Read more at Syracuse.com]

This Post Has One Comment

Lawrence Siskind says:

August 15, 2022 at 11:02 am

If Curaleaf was so incompetent that they mislabeled so much product, it’s hard to argue that they deserve to hold a New York license, and if they were trying to pull a fast one on their uninformed customers in a new lucrative market, then their New York licenses should be revoked. Either way, it’s hard to imagine a weed company so prominent could be so incompetent and/or unprincipled.

Reply

Recent Stories

Kentucky’s Medical Cannabis Program Undergoes Dramatic Transformation: Navigating HB 829 and the Emergency Licensing Regulations

By Hannah King and Arin Aragona Plans for Kentucky’s medical cannabis program took a significant turn last week with the passage of House Bill 829 and the implementation of emergency…

Cannabis in Court: When Federal Courts Will Hear Commercial Disputes Related to the Cannabis Business

By Steven Ascher and Anna M.Windemuth The unique status of the cannabis business — legal in a majority of states, but still illegal under federal law — creates a thorny…

Patchwork Regulation of CBD Products Continues Despite Rise in Demand

By Courtney A. Hunter and Jessalyn H. Zeigler Demand for cannabidiol (CBD) products continues to climb, and the market has risen to the occasion. There is now a robust array…

How Private Equity Trumped Social Equity in State Cannabis Deal

Confidential documents obtained by THE CITY reveal how Chicago Atlantic Group became one of the biggest beneficiaries of the state’s legalization program. Last June, Gov. Kathy Hochul announced that a…